MFG
KURA icon

Merit Financial Group’s Kura Oncology KURA Stock Holding History

Merit Financial Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
23,277
+9,708
+72% +$91.6K ﹤0.01% 1930
2026
Q1 		$110K Sell
13,569
-8,930
-40% -$76.7K ﹤0.01% 2002
2025
Q4 		$234K Buy
22,499
+12,454
+124% +$131K ﹤0.01% 1727
2025
Q3 		$88.9K Buy
+10,045
New +$71.6K ﹤0.01% 1743

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Merit Financial Group's KURA Position: Q2 2026 in Review

Merit Financial Group increased its Kura Oncology (KURA) stake by 72% in Q2 2026, buying an estimated $91.6K and bringing the position to 23,277 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Merit Financial Group first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Merit Financial Group held 23,277 shares of Kura Oncology worth $255K as of Q2 2026.
  • Merit Financial Group bought 9,708 Kura Oncology shares in Q2 2026, an estimated $91.6K.
  • Kura Oncology made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1930 holding.
  • Merit Financial Group first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.